Skip to Content

Drug Interactions between methocarbamol and prabotulinumtoxinA

This report displays the potential drug interactions for the following 2 drugs:

  • methocarbamol
  • prabotulinumtoxinA

Edit list (add/remove drugs)

Interactions between your drugs


methocarbamol prabotulinumtoxinA

Applies to: methocarbamol and prabotulinumtoxinA

Using methocarbamol before or after prabotulinumtoxinA may increase the severity of muscle weakness you may experience from treatment with prabotulinumtoxinA. Let your doctor know if you develop excessive muscle weakness. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions


methocarbamol food

Applies to: methocarbamol

Alcohol can increase the nervous system side effects of methocarbamol such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with methocarbamol. Do not use more than the recommended dose of methocarbamol, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.